Recent progress in studies of neurotrophic factors and their clinical implications
- PMID: 9351702
- DOI: 10.1007/s001090050147
Recent progress in studies of neurotrophic factors and their clinical implications
Abstract
Neurotrophic factors are endogenous soluble proteins that regulate long-term survival and differentiation of neurons of the peripheral and central nervous systems. These factors play an important role in the structural integrity of the nervous system, and therefore are good candidates as therapeutic agents for neurodegenerative diseases. However, recent studies have revealed some unexpected, novel roles of neurotrophic factors. Of particular significance is the discovery of the new functions of brain-derived neurotrophic factor (BDNF) and glia-derived neurotrophic factor (GDNF). Physiological experiments indicate that BDNF may serve as regulatory factors for synaptic transmission as well as for learning and memory. Gene targeting studies demonstrate that GDNF may be essential for development of the enteric nervous system (ENS) and kidney organogenesis. These results not only provide new insights into our understanding of the function of neurotrophic factors but may also have significant implications in the therapeutic usages of neurotrophic factors.
Similar articles
-
Glial cell line-derived neurotrophic factor (GDNF) promotes the survival of axotomized retinal ganglion cells in adult rats: comparison to and combination with brain-derived neurotrophic factor (BDNF).J Neurobiol. 1999 Feb 15;38(3):382-90. doi: 10.1002/(sici)1097-4695(19990215)38:3<382::aid-neu7>3.0.co;2-5. J Neurobiol. 1999. PMID: 10022580
-
Neurturin enhances the survival of axotomized retinal ganglion cells in vivo: combined effects with glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor.Neuroscience. 2002;110(3):555-67. doi: 10.1016/s0306-4522(01)00557-7. Neuroscience. 2002. PMID: 11906793
-
Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo.J Neurosci. 2001 Jan 15;21(2):581-9. doi: 10.1523/JNEUROSCI.21-02-00581.2001. J Neurosci. 2001. PMID: 11160437 Free PMC article.
-
Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF).Microsc Res Tech. 1999 May 15-Jun 1;45(4-5):292-302. doi: 10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8. Microsc Res Tech. 1999. PMID: 10383122 Review.
-
The role of neuronal growth factors in neurodegenerative disorders of the human brain.Brain Res Brain Res Rev. 1998 Jun;27(1):1-39. doi: 10.1016/s0165-0173(98)00004-6. Brain Res Brain Res Rev. 1998. PMID: 9639663 Review.
Cited by
-
Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs.Neurotherapeutics. 2009 Jan;6(1):163-74. doi: 10.1016/j.nurt.2008.10.030. Neurotherapeutics. 2009. PMID: 19110207 Free PMC article. Review.
-
Drug Targets in Neurotrophin Signaling in the Central and Peripheral Nervous System.Mol Neurobiol. 2018 Aug;55(8):6939-6955. doi: 10.1007/s12035-018-0885-3. Epub 2018 Jan 25. Mol Neurobiol. 2018. PMID: 29372544 Free PMC article. Review.
-
Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrain.J Neural Transm (Vienna). 2009 Nov;116(11):1457-72. doi: 10.1007/s00702-009-0225-x. Epub 2009 Apr 25. J Neural Transm (Vienna). 2009. PMID: 19396396
-
Acceleration of blood-brain barrier formation after transplantation of enteric glia into spinal cords of rats.Exp Brain Res. 2005 Mar;162(1):56-62. doi: 10.1007/s00221-004-2119-3. Epub 2004 Dec 15. Exp Brain Res. 2005. PMID: 15599730
-
Putting Cells in Motion: Advantages of Endogenous Boosting of BDNF Production.Cells. 2021 Jan 18;10(1):183. doi: 10.3390/cells10010183. Cells. 2021. PMID: 33477654 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources